Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms

Bone

Volumn 42, Issue 6, 2008, Pages 1131-1136

  Caverzasio, Joseph ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Calcium; Osteoblasts; Proliferation; Signaling; Strontium ranelate

Indexed keywords

CALCIUM CHLORIDE; CATION; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; PROTEIN KINASE D; STRONTIUM RANELATE;

ANIMAL CELL; ARTICLE; BASAL CELL; CELL COUNT; CELL DIVISION; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESENCHYME CELL; NONHUMAN; OSTEOBLAST; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CELL DIVISION; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MESENCHYMAL STEM CELLS; MICE; ORGANOMETALLIC COMPOUNDS; OSTEOBLASTS; PLURIPOTENT STEM CELLS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; THIOPHENES;

EID: 43149125403     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.02.010     Document Type: Article

References (25)

1. Meunier P.J. [Strontium ranelate: new therapeutic agent for postmenopausal osteoporosis]. Med Sci (Paris) 20 (2004) 631-633
2. Reginster J.Y., Sarlet N., Lejeune E., and Leonori L. Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action. Curr Osteoporos Rep 3 (2005) 30-34
3. Meunier P.J., Roux C., Seeman E., Ortolani S., Badurski J.E., and Spector T.D. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
4. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., and Phenekos C. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90 (2005) 2816-2822
5. Seeman E., Vellas B., Benhamou C., Aquino J.P., Semler J., and Kaufman J.M. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21 (2006) 1113-1120
6. Canalis E., Hott M., Deloffre P., Tsouderos Y., and Marie P.J. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18 (1996) 517-523
7. Ammann P., Shen V., Robin B., Mauras Y., Bonjour J.P., and Rizzoli R. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 19 (2004) 2012-2020
8. Ammann P., Badoud I., Barraud S., Dayer R., and Rizzoli R. Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22 (2007) 1419-1425
9. Marie P.J., Hott M., Modrowski D., De Pollak C., Guillemain J., and Deloffre P. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8 (1993) 607-615
10. Baron R., and Tsouderos Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450 (2002) 11-17
11. Takahashi N., Sasaki T., Tsouderos Y., and Suda T. S 12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18 (2003) 1082-1087
12. Bonnelye E., Chabadel A., Saltel F., and Jurdic P. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone (2007)
13. Zhu L.L., Zaidi S., Peng Y., Zhou H., Moonga B.S., and Blesius A. Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun 355 (2007) 307-311
14. Brown E.M., Chattopadhyay N., and Yano S. Calcium-sensing receptors in bone cells. J Musculoskelet Neuronal Interact 4 (2004) 412-413
15. Coulombe J., Faure H., Robin B., and Ruat M. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. Biochem Biophys Res Commun 323 (2004) 1184-1190
16. Chattopadhyay N., Yano S., Tfelt-Hansen J., and Brown E.M. Strontium ranelate promotes chemotaxis, stimulates proliferation and induces genes involved in the differentiation of rat primary osteoblast. Bone 36 S2 (2005) S400
17. Chattopadhyay N., Quinn S.J., Kifor O., Ye C., and Brown E.M. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol 74 (2007) 438-447
18. Pi M., and Quarles L.D. A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. J Bone Miner Res 19 (2004) 862-869
19. Lemonnier J., Ghayor C., Guicheux J., and Caverzasio J. Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation. J Biol Chem 279 (2004) 259-264
20. Knudsen K.E., Diehl J.A., Haiman C.A., and Knudsen E.S. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25 (2006) 1620-1628
21. Choudhary S., Wadhwa S., Raisz L.G., Alander C., and Pilbeam C.C. Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway. J Bone Miner Res 18 (2003) 1813-1824
22. Choudhary S., Halbout P., Alander C., Raisz L., and Pilbeam C. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins. J Bone Miner Res (2007)
23. Yamaguchi T., Chattopadhyay N., Kifor O., Sanders J.L., and Brown E.M. Activation of p42/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line. Biochem Biophys Res Commun 279 (2000) 363-368
24. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H.J., and Johannes F.J. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392 (1996) 77-80
25. Waldron R.T., Rey O., Iglesias T., Tugal T., Cantrell D., and Rozengurt E. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J Biol Chem 276 (2001) 32606-32615